Local Treg Immunomodulation Cures Metastatic Lymphoma Including CNS Sites
Abstract LBA-2 CD4+CD25+FOXP3+ regulatory T-cells (Tregs) protect cancers from the immune system. They express important functional molecules such as CTLA-4 and Ox40 on their surface. Anti-CTLA4 monoclonal antibody (mAb) is the first drug to improve survival of refractory metastatic melanoma. Its re...
Saved in:
Published in | Blood Vol. 118; no. 21; p. LBA-2 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Inc
18.11.2011
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!